Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self

Abstract

International prostate symptom score (IPSS) was claimed to be complicated for patients. The aim of this study was to measure differences in IPSS when introduced by a physician vs self-administration. Patients with lower urinary tract symptoms completed two IPSS questionnaires: one self-administrated and the other by a physician 1 week apart. Results with 75 patients in each group suggested that there was no statistically significant difference between patient and physician administration, although the mean scores of patients’ administration were higher in both groups. In conclusion, when assessing IPSS before treatment, we found no difference between patient administration and physician administration.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Bruskewitz R . Management of symptomatic BPH in US: who is treated and how? Eur Urol 1999; 36: 7–13.

    Article  Google Scholar 

  2. Roehrborn CG . The newly established guidelines for the diagnosis and management of benign prostatic hyperplasia. Curr Opin Urol 1995; 5: 30–35.

    Article  Google Scholar 

  3. Mebust WK, Holtgrewe HL, Cockett ATK, Peter PC and Writing Committee . Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of thirteen participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243–253.

    Article  CAS  Google Scholar 

  4. McConnell JD . Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan Jr ED and Wein AJ (eds). Campbell's Urology, 7th edn. WB Saunders Company: Philadelphia, PA, 1998, pp 1429–1452.

    Google Scholar 

  5. Barry MJ et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–1557.

    Article  CAS  Google Scholar 

  6. Jepsen JV, Bruskewitz RC . Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 1998; 51 (4A Suppl): 13–18.

    Article  CAS  Google Scholar 

  7. Jepsen JV, Bruskewitz RC . Office evaluation of men with lower urinary tract symptoms. Urol Clin North Am 1998; 25: 545–554.

    Article  CAS  Google Scholar 

  8. Lujan Galan M et al. The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia. Arch Esp Urol 1997; 50: 847–853.

    CAS  PubMed  Google Scholar 

  9. MacDiarmid SA et al. An assessment of the comprehension of the American Urological Association Symptom Index. J Urol 1998; 159: 873–874.

    Article  CAS  Google Scholar 

  10. Gee WF et al. 1997 American Urological Association Gallup Survey: changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994–1997. J Urol 1998; 160: 1804–1807.

    Article  CAS  Google Scholar 

  11. Netto Jr NR et al. Latin American study on patient acceptance of the International Prostate Symptom Score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia. Urology 1997; 49: 46–49.

    Article  Google Scholar 

  12. Russo F et al. International prostate symptom score: comparison of doctor and patient. Arch Ital Urol Androl 1998; 70: 15–24.

    CAS  PubMed  Google Scholar 

  13. Cockett ATK . Editorial comment: symptom score in patients with benign prostatic hyperplasia. J Urol 1996; 155: 1959.

    Article  Google Scholar 

  14. Cam K, Senel F, Akman Y, Erol A . The efficacy of an abbreviated model of International Prostate Symptom Score in evaluating benign prostatic hyperplasia. BJU Int 2003; 91: 186–189.

    Article  CAS  Google Scholar 

  15. Plante M et al. The international prostate symptom score: physician versus self-administration in the quantification of symptomatology. Urology 1996; 47: 326–328.

    Article  CAS  Google Scholar 

  16. Netto Jr NR, de Lima ML . The influence of patient education level on the international prostatic symptom score. J Urol 1995; 154: 97–99.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Cam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cam, K., Akman, Y., Cicekci, B. et al. Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self. Prostate Cancer Prostatic Dis 7, 41–44 (2004). https://doi.org/10.1038/sj.pcan.4500683

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500683

Keywords

This article is cited by

Search

Quick links